Advanced Oncotherapy plc (LON:AVO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.
Advanced Oncotherapy Price Performance
The company has a quick ratio of 0.13, a current ratio of 1.26 and a debt-to-equity ratio of 98.71. The company has a 50 day simple moving average of GBX 1.75 and a 200-day simple moving average of GBX 1.75. The stock has a market cap of £9.50 million, a price-to-earnings ratio of -25.00 and a beta of 0.06.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- California Resources Stock Could Be a Huge Long-Term Winner
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Insider Trades May Not Tell You What You Think
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
